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Technical appendix 
Bootstrapping of outbreak data to estimate the proportion of cases due to foodborne transmission 
For each pathogen, we estimated the proportion of cases attributable to foodborne transmission by 
bootstrapping 4,999 replicate samples from the outbreak dataset and obtaining an empirical distribution for 
the proportion of cases involved in foodborne outbreaks. For Giardia and Cryptosporidium, this gave 
unrealistically high values for the proportion attributable to foodborne transmission and we instead based our 
estimates on the proportion of outbreaks that were foodborne. We summarised the resulting distributions by 
fitting a Beta distribution using maximum likelihood. 
For Listeria, for which the six cases observed were all from outbreaks involving foodborne transmission, we set 
a lower boundary for the proportion foodborne by assuming that the next outbreak observed, involving two 
cases, would not be foodborne. This is based on the definition for a general outbreak as an incident involving 
two or more epidemiologically-related cases. We then drew values at random from a Binomial distribution with 
8 observations and 6 successes and fitted a Beta function to the resulting distribution. Similarly, for astrovirus, 
for which no foodborne outbreaks were reported, we set an upper boundary for the proportion foodborne by 
assuming that the next outbreak, involving two cases, would be foodborne, and derived Beta parameters in a 
similar fashion. The parameters from the fitted Beta distributions were then used in the Monte Carlo 
simulation. For adenovirus and sapovirus, for which no outbreaks were reported, we used Beta parameters 
derived from analysis of rotavirus and norovirus outbreaks respectively. 
Bootstrapping of outbreak data to estimate the proportion of cases hospitalised 
Data on hospitalisation in outbreaks were only available from England and Wales. For each reported outbreak 
in the England and Wales dataset (excluding outbreaks that occurred in hospitals and residential institutions), 
we calculated the proportion of outbreak cases that was hospitalised and plotted the resulting distribution for 
the proportion of cases hospitalised. We calculated this by causative organism and separately for all outbreaks 
and for foodborne outbreaks only. There was no major difference in hospitalisation between all outbreaks and 
foodborne outbreaks, so we based estimates of hospitalisation on data from all outbreaks. To account for 
uncertainty in hospitalisation parameters, we used a two-step approach. For each pathogen, we first obtained 
an empirical distribution for the proportion of cases hospitalised by bootstrapping 4,999 replicate samples of 
the outbreak data. For example, if there were 50 reported outbreaks for a given pathogen, we sampled 50 
outbreaks with replacement from this set and calculated the mean proportion of cases hospitalised across the 
outbreak sample, weighted by outbreak size. This was repeated 4,999 times for each pathogen. The 
hospitalisation proportion was weighted by outbreak size because many reported outbreaks involve few cases 
and are therefore unlikely to involve hospitalised cases. The small number of larger outbreaks, on the other 
hand, is potentially more informative for estimating hospitalisation. We then fitted a Beta distribution to the 
bootstrapped data and estimated the corresponding a and b parameters using maximum likelihood. The mean 
hospitalisation proportions for each pathogen and Beta parameters used in Model 1 are given in Table A1. The 
fits of the Beta distributions to the outbreak data are show graphically in Figure A1.  
For Listeria, all reported outbreaks occurred in hospitals, so it was not possible to estimate the hospitalisation 
rate from outbreaks. For adenovirus and sapovirus, no outbreaks were reported. For these two pathogens, 
parameters based on analysis of rotavirus and norovirus outbreaks respectively were used. Bootstrap 
estimates with fitted Beta distributions for the remaining 10 pathogens are shown below. 
Figure A1: Bootstrap estimates of the proportion of cases hospitalised with fitted Beta distributions (shown by red line) by pathogen, UK outbreak 
data 2001-08 
 Deriving priors for the proportion hospitalised (p) from the IID1 and IID2 Studies 
We pooled data from the IID1 and IID2 Studies and calculated, by pathogen, the proportion of cases presenting 
to the GP that were hospitalised. Applying this proportion to the rate of GP consultation gave an estimate of 
the hospitalisation rate. For each pathogen, we used the ratio of this rate to the rate of community IID to 
obtain an estimate of the proportion of cases hospitalised. This approach implicitly assumes that hospitalised 
cases always consult a GP. This is reasonable in the UK, as hospitalisation is likely to occur through a GP 
referral, but potentially disregards a fraction of more severe cases (e.g. cases admitted as a result of an 
emergency hospital visit). However, it was not possible to estimate hospitalisation directly from the IID1 and 
IID2 community cohort study components, as hospitalisation is very uncommon and the two cohort studies 
were not designed to measure the rate of hospitalisation. 
 
To account for uncertainty in the hospitalised proportion, we took 100,000 random samples from the 
distributions of the overall IID rate, cp, and the proportion of GP cases hospitalised, and fitted a Beta function 
to the resulting distribution for the hospitalised proportion using maximum likelihood methods. The estimated 
parameters from this Beta distribution were used to inform the prior values for p in the Bayesian approach 
(Table A2). For VTEC O157, for which hospitalisation information was not available from IID1 and IID2, we used 
a non-informative prior defined by the distribution Beta(1,1). For pathogens for which no hospitalisations were 
observed in the IID1 and IID2 studies, we specified limits to the fitted Beta distributions by assuming that the 
next case observed would have been hospitalised. Thus, for Shigella, with 11 cases and no hospitalisations, we 
obtained Beta parameters for a distribution with a mean equivalent to 1/12=0.087. Empirical bootstrap 
distributions with fitted Beta functions are shown below. 
 
Monte Carlo approach (Model 1) 
We obtained estimates of Fp, Gp and Hp using Monte Carlo simulation, each time drawing at random from each 
parameter distribution in the model. We carried out 100,000 simulations, discarding the first 10% and retaining 
the model outputs for every 10th simulation. We checked model convergence graphically by plotting parameter 
values over time to verify adequate mixing, plotting autocorrelograms and comparing density plots for 
outcome variables by tertile of the simulation chain. The model and associated parameter distributions are 
described below: 
𝐹𝑝 = 𝑁 ∙ 𝑐𝑝 ∙ 𝜋𝑝 
𝐺𝑝 = 𝑁 ∙ 𝑔𝑝 ∙ 𝜋𝑝 
𝐻𝑝 = 𝐹𝑝 ∙ 𝛾𝑝 
log(𝑐𝑝) ~ 𝑁(𝜇𝑐𝑝, 𝜎𝑐𝑝) 
log(𝑔𝑝) ~ 𝑁(𝜇𝑔𝑝, 𝜎𝑔𝑝) 
 𝜋𝑝 ~ Beta(𝑎𝜋𝑝, 𝑏𝜋𝑝) 
𝛾𝑝 ~ Beta(𝑎𝛾𝑝, 𝑏𝛾𝑝) 
From the ensuing distributions of Fp, Gp and Hp, we used the median and central 95% of the distributions as the 
point estimates and 95% credible intervals respectively. Parameter values for each pathogen are given in table 
A1 below. 
Bayesian approach (Models 2 and 3) 
In the Bayesian approach, we included parameters for the prior distributions of p and p. These priors were 
used, together with the outbreak data to obtain posterior distributions for these parameters, which were then 
used in the model as described below: 
𝐹𝑝 = 𝑁 ∙ 𝑐𝑝 ∙ 𝜋𝑝 
𝐺𝑝 = 𝑁 ∙ 𝑔𝑝 ∙ 𝜋𝑝 
𝐻𝑝 = 𝐹𝑝 ∙ 𝛾𝑝 
log(𝑐𝑝) ~ 𝑁(𝜇𝑐𝑝, 𝜎𝑐𝑝) 
log(𝑔𝑝) ~ 𝑁(𝜇𝑔𝑝, 𝜎𝑔𝑝) 
𝑓𝑝 ~ Binomial(𝜋𝑝, 𝑜𝑝) 
                       𝜋𝑝 ~ uniform(𝑢𝜋𝑝, 𝑣𝜋𝑝) 
 ℎ𝑝 ~ Binomial(𝛾𝑝, 𝑚𝑝) 
𝛾𝑝 ~ Beta(𝑎𝛾𝑝, 𝑏𝛾𝑝) 
For each pathogen, p, the parameters fp and op represent the number of cases involved in foodborne and all 
outbreaks respectively. Similarly, hp and mp represent the pathogen-specific number of hospitalisations and GP 
consultations as observed in IID1 and IID2. The prior values for parameters p and p are defined by uniform 
and Beta distributions respectively as described above. In Model 2, the uniform distributions for p were 
informed by data from published multi-pathogen food attribution studies. We used a further model, Model 3, 
with the same structure as Model 2, but with parameters for the prior distribution of p being derived from 
case-control and food attribution studies from the literature review. A full description of parameters for 
models 2 and 3 is given in the technical appendix. 
For each model, we carried out 100,000 simulations to obtain posterior distributions for Fp, Gp and Hp, 
discarding the first 10% and retaining the model outputs for every 10th simulation. We checked for model 
convergence as described for the Monte Carlo approach above. Parameter values for each pathogen are given 
in tables A2 and A3 below.
Table A1: Parameter values for Model 1 
 
Incidence  Proportion foodborne  Proportion hospitalised 
Organism 𝝁𝒄𝒑 𝝈𝒄𝒑 𝝁𝒈𝒑 𝝈𝒈𝒑 Source  𝑷𝑭 𝒂𝝅𝒑 𝒃𝝅𝒑 Source  𝑷𝑯 𝒂𝜸𝒑 𝒃𝜸𝒑 Source 
Bacteria 
     
 
    
 
    
C. perfringens -6.50 0.49 -8.34 0.39 A  0.862 25.0 4.3 D  0.0017 2.0 767.6 D 
Campylobacter -4.68 0.22 -6.66 0.18 A  0.501 6.8 6.5 D  0.0046 3.1 558.7 D 
E. coli O157  -8.11 1.36 -11.51 1.12 A  0.531 14.1 12.8 D  0.2235 34.7 118.7 D 
Listeria -- -- -- -- C  1.000 7.8 3.1 D  -- -- -- H 
Salmonella -7.42 0.71 -8.62 0.46 A  0.904 116.0 12.6 D  0.0751 59.8 728.6 D 
Shigella -9.29 0.97 -9.98 0.27 B  0.222 1.7 4.7 D  0.0260 3.5 117.1 D 
Protozoa 
     
 
    
 
    
Cryptosporidium -7.26 0.69 -8.52 0.45 A  0.051 4.0 73.2 D  0.0362 11.6 302.1 D 
Giardia -7.13 0.67 -9.32 0.56 A  0.167 4.0 11.8 D  0.0073 133.1 16,841.1 D 
Viruses 
     
 
    
 
    
Adenovirus -4.59 0.21 -7.08 0.28 A  -- 4.8 230.3 F  -- 10.6 624.3 F 
Astrovirus -5.24 0.29 -7.82 0.37 A  0.000 3.6 437.6 D  0.2222 7.8 241.1 D 
Norovirus -3.06 0.09 -6.18 0.19 A  0.025 38.7 1,473.6 D  0.0064 26.4 4,037.4 D 
Rotavirus -4.37 0.19 -6.60 0.21 A  0.014 4.8 230.3 D  0.0165 10.6 624.3 D 
Sapovirus -3.65 0.13 -6.46 0.19 A  -- 38.7 1,473.6 G  -- 26.4 4,037.4 G 
PF: Proportion foodborne as estimated from outbreak data; PH: Proportion hospitalised as estimated from outbreak data 
A: IID2 Study; B: 2009 laboratory reports * IID1 reporting ratio; C: 2009 laboratory reports 
D: Outbreak data; F: No outbreak data available, assumed same as rotavirus; G: No outbreak data available, assumed same as norovirus 
H: All reported Listeria outbreaks were in hospitals/residential institutions so hospitalisation parameters could not be estimated 
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Table A2: Parameter values for Model 2 
 
Proportion foodborne  Proportion hospitalised 
 
Binomial likelihood  Uniform prior  Binomial likelihood  Beta prior 
Organism 𝒇𝒑 𝒐𝒑 Source  𝒖𝝅𝒑 𝒗𝝅𝒑 Source   𝒉𝒑 𝒎𝒑 Source  𝒂𝜸𝒑 𝒃𝜸𝒑 Source 
Bacteria 




   
 
   
C. perfringens 1,691 1,964 D  0.761 1.000 [1–7]  2 1,120 D  1.6 277.1 J 
Campylobacter  373 761 D  0.420 0.800 [1–7]  2 424 D  3.5 2,119.3 J 
E. coli O157  564 1,041 D  0.400 0.760 [1–7]  197 877 D  1.0 1.0 K 
Listeria 6 8 D  0.690 1.000 [1,4–6,8]  -- -- H  -- -- 
 
Salmonella 7,128 7,892 D  0.550 0.950 [1–7]  419 5,527 D  1.2 75.3 J 
Shigella 65 310 D  0.082 0.310 [1,5,6,9]  4 153 D  0.9 7.1 J 
Protozoa 




   
 
   
Cryptosporidium 4 65 D  0.000 0.120 [1–3,5,9]  31 836 D  1.2 99.1 J 
Giardia 1 7 D  0.050 0.300 [1–3,5,7]  1 137 D  1.2 150.4 J 
Viruses 




   
 
   
Adenovirus 30 2,338 F  0.000 0.100 [1,2]  20 1,211 F  3.1 1,819.8 J 
Astrovirus 2 285 D  0.005 0.107 [1,2,5]  2 88 D  2.5 1,252.6 J 
Norovirus 1500 58,855 D  0.000 0.390 [1–3,5–7,9,10]  80 12,333 D  3.2 6,124.2 J 
Rotavirus 30 2,338 D  0.005 0.130 [1–3,5,7]  20 1,211 D  3.6 1,295.6 J 
Sapovirus
1 
1500 58,855 G  -- --   80 12,333 G  3.9 3,072.6 J 
Incidence parameters are the same as those for Model 1 
1
 Estimates for sapovirus could not be calculated from this model because of the lack of published data to inform prior parameters 
D: Outbreak data; F: No outbreak data available, assumed same as rotavirus; G: No outbreak data available, assumed same as norovirus 
H: All reported Listeria outbreaks were in hospitals/residential institutions so hospitalisation parameters could not be estimated  
J: IID1 and IID2 GP Presentation Studies; K: Non-informative Beta distribution used  
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Table A3: Parameter values for Model 3 
 
Proportion foodborne  Proportion hospitalised 
 
Binomial likelihood  Uniform prior  Binomial likelihood  Beta prior 
Organism 𝒇𝒑 𝒐𝒑 Source  𝒖𝝅𝒑 𝒗𝝅𝒑 Source   𝒉𝒑 𝒎𝒑 Source  𝒂𝜸𝒑 𝒃𝜸𝒑 Source 
Campylobacter  373 761 D  0.110 1.000 [11–26]  2 424 D  3.5 2,119.3 J 
E. coli O157  564 1,041 D  0.090 0.642 [13,27–29]  197 877 D  1.0 1.0 K 
Listeria 6 8 D  0.180 1.000 [30,31]  -- -- H  1.0 1.0 K 
Salmonella 7,128 7,892 D  0.090 1.000 [13,32–34]  419 5,527 D  1.2 75.3 J 
Incidence parameters are the same as those for Model 1  
D: Outbreak data 
H: All reported Listeria outbreaks were in hospitals/residential institutions so hospitalisation parameters could not be estimated 
J: IID1 and IID2 GP Presentation Studies; K: Non-informative Beta distribution used 
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